Extended Release System of Hypoglycemic Agent Containing Solid Dispersions: Strategies and Mechanisms
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32797
Extended Release System of Hypoglycemic Agent Containing Solid Dispersions: Strategies and Mechanisms

Authors: Amit Kumar, Ramendeep Grawal, Peeyush Sharma, Dinesh Puri, Anil Bhandari

Abstract:

The main perspective of the present study aims at overcoming solubility problems by using the technique of solid dispersion. Repaglinide is a BCS Class II drug, having low aqueous solubility and therefore, low bioavailability. Solid dispersions of repaglinide with different carriers Polyvinyl Pyrrolidone (PVP) and Ethyl Cellulose (EC) in different ratios were prepared by suspending method and Dissolving methods. In vitro release studies revealed that the F7 formulation showed extended drug release. So, the dissolution profile of solid dispersion containing EC and PVP K30 (1: 3) was selected as the best formulation because of its extended drug release among all formulations. In conclusion, solid dispersions of Repaglinide in PVP have shown to be a promising approach to improve the bioavailability of Repaglinide.

Keywords: Ethyl Cellulose, Glibenclamide, Polyvinyl Pyrrolidone, Repaglinide, Solid Dispersion.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1091380

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 2596

References:


[1] Ahuja N, Kishore K, Garg A, Purohit S, Solid Dispersions-Preparation Methods, Pharmaceutical Applications and Evaluation Techniques: A Review, Novel Science International Journal of Pharmaceutical Science, 2012, pp. 103-114.
[2] Arora G et al., Preparation and Evaluation of Solid Dispersions of Modified Gum Karaya and Aceclofenac: Controlled Release Application, Pelagia Research Library, 2011, pp. 142-151.
[3] Bhania SB et al., Preparation and Evaluation of Solid Dispersions of Poorly Soluble Drug Repaglinide, Asian Journal of Biochemical and Pharmaceutical Research, 2011, Vol. 1, pp. 201-221.
[4] Chen X, Wen H, Park K, Challenges and New Technologies of Oral Controlled Release, Published by John Wiley & Sons, 2010, pp. 257-277.
[5] Dixit AK, Sigh RP, Singh S, Solid Dispersion- A Strategy for Improving the Solubility of Poorly Soluble Drugs, International Journal of Research in Pharmaceutical and Biomedical Sciences, 2012, June, pp. 960-966.
[6] Gupta A, Nagar M, Sharma P, Formulation and Evaluation of Repaglinide Microspheres, International Journal of Pharmacy and Life Sciences, 2012, pp. 1437-1440.
[7] Jatwani S, Rana AC, Singh G, Aggarwal G, An Overview on Solubility Enhancement Techniques for Poorly Soluble Drugs and Solid Dispersion as an Eminent Strategic Approach, International Journal of Pharmaceutical Sciences and Research, 2012, March, pp. 942-956.
[8] Kavitha K, Puneet KP, Development and Evaluation of Rosiglitazone Maleate Floating Tablets, International Journal of Applied Pharmaceutics, Vol 2, 2010, pp. 6-10.
[9] Kavitha R, Sathali AA, Enhancement of Solubility of Repaglinide by Solid Dispersion Technique, International Journal of Chemical Sciences, 2012, pp. 377-390.
[10] Kumar DP., Arora V., Solid Dispersions: A Review, Journal of Pharaceutical and Scientific Innovation, 2012, pp. 27-34.
[11] Kumar DA, kumar PK, Ranjhita D, Muethy PN, Kumar PA, Method Development, Validation and Stability Study of Repaglinide in Bulk and Pharmaceutical Dosage form by UV Spectrometric Method, International Journal of Biological and Pharmaceutical Research, 2011, pp. 7-10.
[12] Lachman L, Lieberman HA, Pharmaceutical Dosage form: Parentral Medication, Printed by Replica Press Pvt. Ltd, India, vol. 1, 1992, pp. 115-144.
[13] Modi SA, Gaikwad PD, Bhankar BH, Pwar SP, Sustained Release Drug Delivery System: A Review, International Journal of Pharma. Research & Development-Online, 2011, pp. 147-160.
[14] Modi VS, Thorat YS, Dhavale SC, Formulation and Evaluation of Controlled Release Delivery of Trmadol Hydrochloride, International Journal of Chemtech Research, 2012, March, pp. 669-675.
[15] Mohanachandran PN, Sidhumol PG, Kiran TS, Enhancement of Solubility and Dissolution Rate: An Overview, International journal of Comprehensive Pharmacy, Vol. 1, 2010, pp. 1-10.
[16] Nair S, Walikhindi AK, Jamkandi VJ, Formulation and Evaluation of Repaglinide Microspheres, International Journal of Pharmacy and Life Sciences, 2010, pp. 191-196.
[17] Ohara T et al, Dissolution Mechanism of Poorly Water-Soluble Drug from Extended Release Solid Dispersion System with EC and HPMC, International Journal of Pharmaceutics, 2005, pp. 95-102.
[18] Hemnani M et.al, Matrix Tablet: A Tool of Controlled Drug Delivery, American Journal of Pharmtech Research, 2011, November, pp. 1-17.
[19] Patel M, pandya N, Bhaskar VH, Preparation, Characterization and in vitro Evaluation of Repaglinide Binary Solid Dispersions with Hydrophilic Polymers, International Journal of Drug Development & Research, Vol. 3, 2011, pp. 111-121.
[20] Patidar K, Kshirsagar MD, Saini V, Joshi PB, Soni M, Solid Dispersion Technology: A Boon for Poor Water Soluble Drugs, Indian Journal of Noval Drug Delivery, 2011, june, pp. 83-90.
[21] Patel NR et. al, Formulation and Evaluation of Controlled Release Matrix Tablets of a Model Antibiotic Drug, American Journal of Pharmtech Research, 2012, March, pp. 1-14.
[22] Rowe RC, Sheskey PJ, Quinn M, Handbook of Pharmaceutical Excipients, Pharmaceutical Presss, 6th edition, pp. 278, 611.
[23] Rathore DS, Thakur RR, Narwal S, Solid Dispersion: A New Horizon in Novel Drug Delivery System, Journal of Pharmacy Research, 2012, February, pp. 1007-1014.
[24] Shinde SS, Patil SS, Mevkari FI, Satpute AS, An Approach for Solubility Enhancement: Solid Dispersion, International of Advances in Pharmaceutical Sciences, 2012, pp. 299-308.
[25] Sonali D et al., Silymarin-Solid Dispersions: Characterization and Influence of Preparation Methods on Dissolution, Acta Pharm. 60, 2010, pp. 427-443.
[26] Shams T et al., Thermal Infrared Characterization and in vitro Evaluation of Repaglinide Solid Dispersion, Scholars Research Library-Der pharmacia lettre, 2011, pp. 142-150.
[27] Singh S., Bhagel RS., Yadav L., A Review on Solid Dispersion, International Journal of Pharmacy and Life Sciences, Vol. 2, 2011, pp. 1078-1095.
[28] Sweetman s.c; "Martindale- The Complete Drug Referenceā€; 36th Edition; Pharmaceutical Press- 2009; pp. 457,458.
[29] Tiwari R et al., Solid Dispersions: An Overview to Modify Bioavailability of Poorly Water Soluble Drugs, International Journal of PharmTech Research, Vol. 1, 2009, pp. 1338-1349.
[30] Tripathi KD, Essentials of Medical Pharmacology, 6th edition, Jaypee Brothers Medical Publishers Ltd, 2008, pp. 268,269.
[31] Verma S, Rawat A, Kaul M, Saini S, Solid Dispersion: A Strategy for Solubility Enhancement, International Journal of Pharmacy and Technology, 2011, June, pp. 1062-1099
[32] Vasconcelos T, Sarmento B, Costa P, Solid Dispersion as Strategy to Improve Oral Bioavailability of Poor Water Soluble Drugs, Vol. 12, 2007, pp. 1068-1075.